Prostate cancer
Results
Phase 2
This trial was done to see if adding atorvastatin to hormone therapy can slow down the growth of prostate cancer.
It was open for people to join between 2017 and 2019. The team analysed the results in 2020.
Recruitment start: 1 January 2017
Recruitment end: 31 July 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Hing Leung
CRUK Glasgow Clinical Trials Unit
NHS Greater Glasgow and Clyde
Prostate Cancer UK
University of Glasgow
Last reviewed: 15 May 2024
CRUK internal database number: 13881